Alvikas Jurgis, Lo Winifred, Tohme Samer, Geller David A
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Division of Hepatobiliary and Pancreatic Surgery, University of Pittsburgh Medical Center, 3459 Fifth Avenue, MUH 7S, Pittsburgh, PA 15213, USA.
Cancers (Basel). 2023 Feb 12;15(4):1179. doi: 10.3390/cancers15041179.
Hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM) are the two most common malignant tumors that require liver resection. While liver transplantation is the best treatment for HCC, organ shortages and high costs limit the availability of this option for many patients and make resection the mainstay of treatment. For patients with CRLM, surgical resection with negative margins is the only potentially curative option. Over the last two decades, laparoscopic liver resection (LLR) has been increasingly adopted for the resection of a variety of tumors and was found to have similar long-term outcomes compared to open liver resection (OLR) while offering the benefits of improved short-term outcomes. In this review, we discuss the current literature on the outcomes of LLR vs. OLR for patients with HCC and CRLM. Although the use of LLR for HCC and CRLM is increasing, it is not appropriate for all patients. We describe an approach to selecting patients best-suited for LLR. The four common difficulty-scoring systems for LLR are summarized. Additionally, we review the current evidence behind the emerging robotically assisted liver resection technology.
肝细胞癌(HCC)和结直肠癌肝转移(CRLM)是两种最常见的需要进行肝切除的恶性肿瘤。虽然肝移植是HCC的最佳治疗方法,但器官短缺和高昂费用限制了许多患者获得这一治疗选择的机会,使得肝切除成为主要的治疗手段。对于CRLM患者,切缘阴性的手术切除是唯一可能治愈的选择。在过去二十年中,腹腔镜肝切除术(LLR)已越来越多地用于各种肿瘤的切除,并且发现与开放肝切除术(OLR)相比,LLR具有相似的长期疗效,同时还具有改善短期疗效的优势。在本综述中,我们讨论了关于LLR与OLR治疗HCC和CRLM患者疗效的当前文献。虽然LLR在HCC和CRLM治疗中的应用正在增加,但并非适用于所有患者。我们描述了一种选择最适合LLR患者的方法。总结了LLR的四种常见难度评分系统。此外,我们回顾了新兴的机器人辅助肝切除技术背后的当前证据。